Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

21.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.8K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

15.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating microRNA profiles associated with tick bite and debilitating symptom complexes attributed to ticks (DSCATT).

Scientific reports·2026
Same author

Meta-analysis of functional genomics studies reveals conserved cellular pathways required by viruses of pandemic concern.

Access microbiology·2026
Same author

Development and validation of a serum microRNA biomarker panel for bovine Johne's disease.

Journal of dairy science·2026
Same author

A scalable, multi-resolution consensus clustering approach for prioritizing robust signals from high-throughput screens.

Briefings in bioinformatics·2026
Same author

Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile.

The Journal of pathology·2026
Same author

Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational Status.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Sep 13, 2025

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
14:58

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions

Published on: March 5, 2022

4.4K

Genome-wide analysis of host-encoded microRNAs modulating SARS-CoV-2 infection.

Christina L Rootes1, Karla J Cowley2, Aaron M Brice1

  • 1CSIRO Health & Biosecurity, Australian Centre for Disease Preparedness, Geelong, VIC, Australia.

Scientific Data
|July 31, 2025
PubMed
Summary

Researchers screened microRNAs (miRNAs) to understand their role in SARS-CoV-2 replication. This study identified specific miRNAs that either promote or inhibit the virus, offering new therapeutic targets for COVID-19.

More Related Videos

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

6.2K
In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.7K

Related Experiment Videos

Last Updated: Sep 13, 2025

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
14:58

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions

Published on: March 5, 2022

4.4K
Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

6.2K
In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.7K

Area of Science:

  • Virology
  • Genomics
  • Immunology

Background:

  • Viruses utilize host cell machinery for replication, presenting potential therapeutic targets.
  • Genome-wide CRISPR screens revealed cellular pathways critical for SARS-CoV-2 infection, including vesicular transport, lipid metabolism, and PI3K signaling.
  • Understanding host-encoded microRNAs (miRNAs) offers an unbiased approach to investigate the host-pathogen interaction in SARS-CoV-2 infection.

Purpose of the Study:

  • To conduct a functional genomics-driven analysis of host-encoded miRNAs affecting SARS-CoV-2 infection.
  • To identify novel host factors and pathways influencing viral replication through miRNA interactions.
  • To discover potential miRNA-based therapeutic strategies against SARS-CoV-2.

Main Methods:

  • Genome-wide complementary miRNA mimic and inhibitor screens were performed.
  • Experiments were conducted in a bio-safety level 4 (BSL-4) laboratory setting.
  • High-throughput robotics, high-content imaging, and advanced data analysis pipelines were employed.

Main Results:

  • Identification of specific microRNAs that promote SARS-CoV-2 replication.
  • Identification of specific microRNAs that inhibit SARS-CoV-2 replication.
  • A dataset of host miRNAs impacting the SARS-CoV-2 life cycle was generated.

Conclusions:

  • The study identified key host miRNAs that modulate SARS-CoV-2 replication.
  • These findings provide insights into the host-pathogen interface during COVID-19 infection.
  • The identified miRNAs represent potential targets for developing novel antiviral therapeutics against SARS-CoV-2.